Machelle Sanders, director at Biocryst Pharmaceuticals Inc. ($BCRX), sold BCRX shares once on the open market in the last year for a total of $68,544. Her most recent sale occurred on November 13, 2025. These sales rank her 10,042nd among 11,678 insiders by amount sold, well below the average of $8.6 million across 6.4 transactions. Sanders made no open market purchases of BCRX stock.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 13, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | S | Common Stock | 9600 | $7.14 | 30,642.0000 | 219,885,000 | 23.86% | 0.00% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Automatic Stock Option Grant | 27181 | $0.00 | 27,181.0000 | 206,696,000 | 9999.99% | 0.01% |
| June 12, 2025 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Common Stock | 12500 | $0.00 | 40,242.0000 | 206,696,000 | 45.06% | 0.01% |
| June 10, 2025 | Fortrea Holdings Inc. | $FTRE | SANDERS MACHELLE | Director | A | Restricted Stock Unit | 38817 | $0.00 | 38,817.0000 | 90,200,000 | 9999.99% | 0.04% |
| May 14, 2025 | Fortrea Holdings Inc. | $FTRE | SANDERS MACHELLE | Director | M | Common Stock | 7282 | $0.00 | 7,282.0000 | 90,200,000 | 9999.99% | 0.01% |
| May 14, 2025 | Fortrea Holdings Inc. | $FTRE | SANDERS MACHELLE | Director | M | Restricted Stock Unit | 7282 | $0.00 | 0.0000 | 90,200,000 | 100.00% | 0.01% |
| June 17, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | S | Common Stock | 4689 | $6.00 | 27,742.0000 | 192,198,000 | 14.46% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Common Stock | 6820 | $0.00 | 32,431.0000 | 192,198,000 | 26.63% | 0.00% |
| June 12, 2024 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Automatic Stock Option Grant | 49933 | $0.00 | 49,933.0000 | 192,198,000 | 9999.99% | 0.03% |
| May 14, 2024 | Fortrea Holdings Inc. | $FTRE | SANDERS MACHELLE | Director | A | Restricted Stock Unit | 7282 | $0.00 | 7,282.0000 | 0 | 9999.99% | 0.00% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Automatic Stock Option Grant | 39072 | $0.00 | 39,072.0000 | 185,908,000 | 9999.99% | 0.02% |
| June 13, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | A | Common Stock | 16745 | $0.00 | 29,611.0000 | 185,908,000 | 130.15% | 0.01% |
| June 15, 2023 | BIOCRYST PHARMACEUTICALS INC | $BCRX | SANDERS MACHELLE | Director | S | Common Stock | 4000 | $7.98 | 25,611.0000 | 185,908,000 | 13.51% | 0.00% |